About Nanovery
Nanovery is a company based in London (United Kingdom) founded in 2018 by Jurek Kozyra.. Nanovery has raised $2.12 million across 5 funding rounds from investors including Gov.uk, European Commission and UK Research and Innovation. The company has 1 employees as of November 30, 2020. Nanovery offers products and services including ASO Bioanalysis, siRNA Bioanalysis, Custom Assay Development, microRNA Biomarkers, and miRometer-122™ Technology. Nanovery operates in a competitive market with competitors including Scholar Rock, Fluxion Biosciences, Ionpath, SamanTree Medical and Phase Focus, among others.
- Headquarter London, United Kingdom
- Employees 1 as on 30 Nov, 2020
- Founders Jurek Kozyra
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanovery Limited
- Date of Incorporation 26 Nov, 2018
- Jurisdiction NEWCASTLE UPON TYNE, TYNE AND WEAR, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.12 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Gov.uk
& 8 more
-
Employee Count
1
as on Nov 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanovery
Nanovery offers a comprehensive portfolio of products and services, including ASO Bioanalysis, siRNA Bioanalysis, Custom Assay Development, microRNA Biomarkers, and miRometer-122™ Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for analyzing antisense oligonucleotides in samples.
Quantifies small interfering RNA for research applications.
Creates tailored assays for nucleic acid detection needs.
Identifies and analyzes microRNA for diagnostic purposes.
Provides precise quantification of specific microRNA biomarkers.
Unlock access to complete
Unlock access to complete
Funding Insights of Nanovery
Nanovery has successfully raised a total of $2.12M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(28 Jun 2021)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Seed - Nanovery | Valuation |
investors |
|
| Apr, 2025 | Amount | Grant - Nanovery | Valuation |
investors |
|
| Apr, 2023 | Amount | Grant - Nanovery | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nanovery
Nanovery has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, European Commission and UK Research and Innovation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment finance is provided to small and medium-sized enterprises.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in UK companies across diverse sectors.
|
Founded Year | Domain | Location | |
|
Investments in early-stage tech startups are made by Earlymarket.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanovery
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nanovery
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanovery Comparisons
Competitors of Nanovery
Nanovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, Fluxion Biosciences, Ionpath, SamanTree Medical and Phase Focus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based tools for cellular analysis are provided.
|
|
| domain | founded_year | HQ Location |
Multiplexed ion beam imaging platform for tissue biopsies is developed.
|
|
| domain | founded_year | HQ Location |
A surgical digital microscope for tumor resection is developed.
|
|
| domain | founded_year | HQ Location |
Provider of virtual lens that generates High definition images without high-quality lenses
|
|
| domain | founded_year | HQ Location |
Solutions for image-guided interventional procedures are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanovery
Frequently Asked Questions about Nanovery
When was Nanovery founded?
Nanovery was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is Nanovery located?
Nanovery is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Nanovery a funded company?
Nanovery is a funded company, having raised a total of $2.12M across 5 funding rounds to date. The company's 1st funding round was a Grant of $935.63K, raised on Jun 28, 2021.
How many employees does Nanovery have?
As of Nov 30, 2020, the latest employee count at Nanovery is 1.
What does Nanovery do?
Nanovery was founded in 2018 and is based in London, United Kingdom. Operations focus on the biotechnology sector, where nanotechnology and artificial intelligence are combined to create diagnostic tools. Nanobots are designed for injection into the bloodstream, enabling detection of specific cancer cell mutations. Upon identification, the nanobots illuminate the affected areas to aid in early diagnosis. The approach targets improvements in cancer detection accuracy.
Who are the top competitors of Nanovery?
Nanovery's top competitors include Scholar Rock, Ionpath and SamanTree Medical.
What products or services does Nanovery offer?
Nanovery offers ASO Bioanalysis, siRNA Bioanalysis, Custom Assay Development, microRNA Biomarkers, and miRometer-122™ Technology.
Who are Nanovery's investors?
Nanovery has 9 investors. Key investors include Gov.uk, European Commission, UK Research and Innovation, European Union, and North East Fund.